xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156350 | pep 93-106 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KSLTALTNKITAWK | 14 | null | 93 | 106 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855295 | 34 | Table 1 | Positive | true | null | 9479 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156350 | pep 93-106 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KSLTALTNKITAWK | 14 | null | 93 | 106 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855296 | 37 | Figure 7 | Positive | true | null | 9986 | null | null | null | null | null | null | null | null | Representative selection | Exact match to reference information | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156350 | pep 93-106 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KSLTALTNKITAWK | 14 | null | 93 | 106 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855297 | 37 | Figure 7 | Positive | true | null | 9986 | null | null | null | null | null | null | null | null | Representative selection | Exact match to reference information | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156417 | pep 101-116 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QILGEKSLTALTN | 13 | null | 88 | 100 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855298 | 34 | Table 1 | Positive | true | null | 9479 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156417 | pep 101-116 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QILGEKSLTALTN | 13 | null | 88 | 100 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855300 | 37 | Figure 7 | Positive | true | null | 9986 | null | null | null | null | null | null | null | null | Representative selection | Exact match to reference information | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156417 | pep 101-116 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QILGEKSLTALTN | 13 | null | 88 | 100 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855299 | 37 | Figure 7 | Positive | true | null | 9986 | null | null | null | null | null | null | null | null | Representative selection | Exact match to reference information | null | 4 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156406 | pep 110-122 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QARQQKNLEFSDK | 13 | null | 110 | 122 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855312 | 34 | Table 1 | Positive | true | null | 9479 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
974.xml | 974 | 2026-02-03-08:00 | 1370431 | 1,992 | Myosin-cross-reactive epitope of Shigella flexneri invasion plasmid antigen B. | Infection and immunity | E V Oaks; K R Turbyfill | 156347 | pep 115-130 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KNLEFSDKINTLLSET | 16 | null | 115 | 130 | 623 | P18011.2 | null | Epitope containing region/antigenic site | Representative selection | BCell | 1855315 | 34 | Table 1 | Positive | true | null | 9479 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
975.xml | 975 | 2025-11-06-08:00 | 7690424 | 1,993 | Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8- cytotoxic T-cell clone. | Journal of virology | I Kurane; L C Dai; P G Livingston; E Reed; F A Ennis | 12605 | NS3 255-264 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EIVDLMCHAT | 10 | null | 255 | 264 | 408871 | NP_740321.1 | null | Exact Epitope | Not determined | TCell | 11924 | 67 | Table 1 and figure 1 | Positive | true | null | 9606 | null | null | DOID:12205 | 79 | null | T cell CD4+ | null | Cell Line / Clone | Exact match to reference information | Not determined | null | 3 |
977.xml | 977 | 2026-02-03-08:00 | 7687804 | 1,993 | Peptides shorter than a minimal CTL epitope may have a higher binding affinity than the epitope for the class I Kk molecule. | Virology | J Cossins; K Gould; G G Brownlee | 57322 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | SDYEGRLI | 8 | null | 50 | 57 | 211044 | null | null | Exact Epitope | Not determined | TCell | 11953 | 67 | Figure 1A | Positive | true | null | 10000228 | F | 3 months | ONTIE:0003423 | 125 | null | T cell | null | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
977.xml | 977 | 2026-02-03-08:00 | 7687804 | 1,993 | Peptides shorter than a minimal CTL epitope may have a higher binding affinity than the epitope for the class I Kk molecule. | Virology | J Cossins; K Gould; G G Brownlee | 73670 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | YEGRLI | 6 | null | 52 | 57 | 211044 | null | null | Exact Epitope | Not determined | MhcBinding | 14486 | 226 | Figure 1B | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953574 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953577 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953742 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953619 | 34 | Table 4 | Positive-Intermediate | true | null | 9606 | null | null | DOID:0060499 | null | null | null | null | null | Representative selection | null | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953616 | 34 | Table 4 | Positive-High | true | null | 9606 | null | null | DOID:0060499 | null | null | null | null | null | Representative selection | null | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953617 | 34 | Table 4 | Positive-High | true | null | 9606 | null | null | DOID:0060499 | null | null | null | null | null | Exact match to reference information | null | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953741 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138830 | GA1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953618 | 34 | Table 4 | Positive-High | true | null | 9606 | null | null | DOID:0060499 | null | null | null | null | null | Representative selection | null | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953578 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953579 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953744 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953599 | 34 | Table 4 | Positive-High | true | null | 9606 | null | 29 years | DOID:0060499 | null | null | null | null | null | Exact match to reference information | null | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953600 | 34 | Table 4 | Positive-High | true | null | 9606 | null | 29 years | DOID:0060499 | null | null | null | null | null | Representative selection | null | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953743 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953745 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953746 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953583 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953584 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139429 | GD1a | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953747 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 2 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139429 | GD1a | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953748 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 2 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139429 | GD1a | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953585 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 2 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139429 | GD1a | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953586 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 2 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953749 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953587 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953588 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953750 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953751 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953589 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953694 | 34 | Table 4 | Positive-Intermediate | true | null | 10000038 | M | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953695 | 34 | Table 4 | Positive-Intermediate | true | null | 10000038 | M | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953696 | 34 | Table 4 | Positive-Intermediate | true | null | 10000038 | M | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953590 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953623 | 34 | Table 4 | Positive-High | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Representative selection | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953625 | 34 | Table 4 | Positive-Low | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Representative selection | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953627 | 34 | Table 4 | Positive-High | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Representative selection | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953621 | 34 | Table 4, Figure 3 | Positive-Low | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Representative selection | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953622 | 34 | Table 4 | Positive-High | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Exact match to reference information | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953624 | 34 | Table 4 | Positive-Intermediate | true | null | 9606 | F | 67 years | DOID:5213 | null | null | null | null | null | Representative selection | null | null | 1 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953752 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953753 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953738 | 34 | Table 4 | Positive-Intermediate | true | null | 10000038 | M | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953739 | 34 | Table 4 | Positive-Low | true | null | 10000038 | M | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953740 | 34 | Table 4 | Positive-Low | true | null | 10000038 | M | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953592 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
978.xml | 978 | 2026-02-03-08:00 | 11854201 | 2,002 | Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. | Infection and immunity | C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953596 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
979.xml | 979 | 2025-11-06-08:00 | 8546009 | 1,995 | Identification of Kk-restricted T-cell epitope within influenza virus nucleoprotein. | Virus research | K Kuroda; M Nakajima; H Minakata; Y Hosaka | 57322 | NP50-57 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SDYEGRLI | 8 | null | 50 | 57 | 211044 | null | null | Exact Epitope | Representative selection | TCell | 11959 | 67 | Figures 1 and 2 | Positive | true | null | 10000236 | null | null | null | 125 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
979.xml | 979 | 2025-11-06-08:00 | 8546009 | 1,995 | Identification of Kk-restricted T-cell epitope within influenza virus nucleoprotein. | Virus research | K Kuroda; M Nakajima; H Minakata; Y Hosaka | 57322 | NP50-57 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SDYEGRLI | 8 | null | 50 | 57 | 211044 | null | null | Exact Epitope | Representative selection | MhcLigandElution | 14454 | 92 | Figure 3 | Positive | true | null | null | null | null | null | 125 | null | null | null | null | null | null | null | 4 |
980.xml | 980 | 2025-11-06-08:00 | 8613379 | 1,996 | A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. | Infection and immunity | L L An; E Pamer; J L Whitton | 23376 | LLO 91-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GYKDGNEYI | 9 | null | 91 | 99 | 1639 | P13128.1 | null | Exact Epitope | Not determined | TCell | 14528 | 67 | Figure 3C | Positive | true | null | 10000019 | null | null | null | 124 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 5 |
980.xml | 980 | 2025-11-06-08:00 | 8613379 | 1,996 | A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. | Infection and immunity | L L An; E Pamer; J L Whitton | 23376 | LLO 91-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GYKDGNEYI | 9 | null | 91 | 99 | 1639 | P13128.1 | null | Exact Epitope | Not determined | TCell | 14533 | 182 | Figure 4 | Positive | true | null | 10000019 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 5 |
980.xml | 980 | 2025-11-06-08:00 | 8613379 | 1,996 | A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. | Infection and immunity | L L An; E Pamer; J L Whitton | 23376 | LLO 91-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GYKDGNEYI | 9 | null | 91 | 99 | 1639 | P13128.1 | null | Exact Epitope | Not determined | TCell | 14542 | 638 | Figure 6 | Positive | true | null | 10000019 | null | null | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 5 |
980.xml | 980 | 2025-11-06-08:00 | 8613379 | 1,996 | A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. | Infection and immunity | L L An; E Pamer; J L Whitton | 23376 | LLO 91-99 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GYKDGNEYI | 9 | null | 91 | 99 | 1639 | P13128.1 | null | Exact Epitope | Not determined | TCell | 14525 | 67 | Figure 2B, Figure 2A | Positive | true | null | 10000216 | null | null | ONTIE:0003423 | 124 | null | T cell | lymphoid | Cell Line / Clone | Exact match to reference information | Not determined | null | 5 |
981.xml | 981 | 2026-02-03-08:00 | 8725098 | 1,996 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. | Virus research | C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes | 7445 | peptide D | FragmentOfANaturalSequenceMolecule | Peptide from protein | CYTVSDSSFFSYGEIPFGVTDGPRYC | 26 | null | 373 | 398 | 11151 | P07946.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 12009 | 316 | Table 1 | Positive | true | null | 10000188 | null | 2 months | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
981.xml | 981 | 2026-02-03-08:00 | 8725098 | 1,996 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. | Virus research | C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes | 7445 | peptide D | FragmentOfANaturalSequenceMolecule | Peptide from protein | CYTVSDSSFFSYGEIPFGVTDGPRYC | 26 | null | 373 | 398 | 11151 | P07946.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 12038 | 199 | Figure 3A | Positive | true | null | 10000206 | null | 2 months | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
981.xml | 981 | 2026-02-03-08:00 | 8725098 | 1,996 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. | Virus research | C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes | 7445 | peptide D | FragmentOfANaturalSequenceMolecule | Peptide from protein | CYTVSDSSFFSYGEIPFGVTDGPRYC | 26 | null | 373 | 398 | 11151 | P07946.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 12008 | 316 | Table 1, Table 2 | Positive | true | null | 10000206 | null | 2 months | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
981.xml | 981 | 2026-02-03-08:00 | 8725098 | 1,996 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. | Virus research | C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes | 7445 | peptide D | FragmentOfANaturalSequenceMolecule | Peptide from protein | CYTVSDSSFFSYGEIPFGVTDGPRYC | 26 | null | 373 | 398 | 11151 | P07946.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 12043 | 199 | Figure 3B | Positive | true | null | 10000206 | null | 2 months | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
981.xml | 981 | 2026-02-03-08:00 | 8725098 | 1,996 | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. | Virus research | C Smerdou; I M Anton; J Plana; R Curtiss; L Enjuanes | 7445 | peptide D | FragmentOfANaturalSequenceMolecule | Peptide from protein | CYTVSDSSFFSYGEIPFGVTDGPRYC | 26 | null | 373 | 398 | 11151 | P07946.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 12007 | 199 | Table 1 | Positive | true | null | 10000188 | null | 2 months | null | null | null | null | null | null | Not determined | Exact match to reference information | null | 8 |
982.xml | 982 | 2025-11-06-08:00 | 8613407 | 1,996 | Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules. | Infection and immunity | H L Zwickey; T A Potter | 34446 | p60 epitope | FragmentOfANaturalSequenceMolecule | Peptide from protein | KYGVSVQDI | 9 | null | 217 | 225 | 1639 | P21171.2 | null | Exact Epitope | Representative selection | TCell | 1806727 | 67 | FIgure 3 | Positive | true | null | 10000216 | null | null | null | 124 | null | T cell CD8+ | null | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 3 |
982.xml | 982 | 2025-11-06-08:00 | 8613407 | 1,996 | Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules. | Infection and immunity | H L Zwickey; T A Potter | 34446 | p60 epitope | FragmentOfANaturalSequenceMolecule | Peptide from protein | KYGVSVQDI | 9 | null | 217 | 225 | 1639 | P21171.2 | null | Exact Epitope | Representative selection | TCell | 1806726 | 67 | FIgures 1, 2 and 3 | Positive | true | null | 10000216 | null | null | null | 124 | null | T cell CD8+ | null | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 3 |
982.xml | 982 | 2025-11-06-08:00 | 8613407 | 1,996 | Peptide epitopes from noncytosolic Listeria monocytogenes can be presented by major histocompatibility complex class I molecules. | Infection and immunity | H L Zwickey; T A Potter | 34446 | p60 epitope | FragmentOfANaturalSequenceMolecule | Peptide from protein | KYGVSVQDI | 9 | null | 217 | 225 | 1639 | P21171.2 | null | Exact Epitope | Representative selection | TCell | 1806725 | 67 | FIgures 1, 2 and 3 | Positive | true | null | 10000216 | null | null | null | 124 | null | T cell CD8+ | null | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 3 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953480 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953464 | 34 | Tables 1 and 4 | Positive | true | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953479 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953463 | 34 | Tables 1 and 4 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 143251 | GM2 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953496 | 34 | Text page 264 | Positive | true | null | 9606 | null | null | DOID:12842 | null | null | null | null | null | Exact match to reference information | null | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953482 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953483 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953465 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 142077 | GM1 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953466 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953484 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953485 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953468 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 138831 | GD1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953467 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 144143 | GT1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953470 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 144143 | GT1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953469 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 144143 | GT1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953486 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 144143 | GT1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953487 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953471 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953472 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953488 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 130673 | GQ1b | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953489 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953474 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953473 | 34 | Table 1 | Positive | true | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953491 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139967 | GD3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953490 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 1 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139968 | GM3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953476 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139968 | GM3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953475 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139968 | GM3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953493 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:104 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139968 | GM3 | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953492 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
983.xml | 983 | 2025-09-11-07:00 | 11164910 | 2,001 | Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. | Journal of neuroimmunology | K Kaida; S Kusunoki; K Kamakura; K Motoyoshi; I Kanazawa | 139429 | GD1a | AccessionNonSequenceMolecule | Glycolipid | null | null | null | null | null | 9606 | null | null | Epitope containing region/antigenic site | Representative selection | BCell | 1953478 | 34 | Table 1 | Negative | false | null | 9606 | null | null | DOID:934 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 2 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.